NaveenPremnathMD

Hematologic Oncology, Hospice & Palliative

Assistant Professor

Telehealth Available

Overview of Dr. Premnath

Dr. Naveen Premnath is an oncologist in Minneapolis, MN and is affiliated with multiple hospitals in the area, including M Health Fairview University of Minnesota Medical Center and M Health Fairview St. John's Hospital. He received his medical degree from All India Institute of Medical Sciences and has been in practice 3 years. He is one of 88 doctors at M Health Fairview University of Minnesota Medical Center and one of 18 doctors at M Health Fairview St. John's Hospital who specialize in Oncology. He has more than 20 publications and over 50 citings.

Office
500 Harvard Street SE
Minneapolis, MN 55455
Book by Phone+1(567) 350-1128

Education & Training

University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2020
University of Texas Southwestern Medical CenterFellowship, Hospice and Palliative Medicine, 2019 - 2020
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2016 - 2019
All India Institute of Medical SciencesClass of 2013

Certifications & Licensure

MN State Medical License 2023 - 2025
TX State Medical License 2020 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Hospice and Palliative Medicine
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Use and Spending on Medical Equipment Among US Cancer Survivors.
Faraz I Jafri, Vishal R Patel, Syed M Qasim Hussaini, Naveen Premnath, Helen M Parsons
JAMA Network Open. 2025-01-02
Impact of the Affordable Care Act and Medicaid Expansion Among Patients With HIV-Associated Aggressive B-Cell Non-Hodgkin Lymphomas.
Naveen Premnath, Yulun Liu, Heather Reves, Urvashi Pandey, Rasmi G Nair
JCO Oncology Practice. 2024-10-17
Racial and ethnic disparities in Acute Myeloid Leukemia: 15-year experience at a safety net hospital system.
Sharlene Dong, Naveen Premnath, Navid Sadeghi, Radhika Kainthla, Stephen S Chung
Leukemia Research. 2024-06-01

Journal Articles

BReast CAncer (BRCA) Gene Mutations as an Emerging Biomarker for the Treatment of Gastrointestinal Malignancies
Naveen Premnath, MD, Annals of Palliative Medicine
Assessment of Racial Differences in Rates of Autopsy in the US, 2008-2017
Naveen Premnath, MD, JAMA Internal Medicine

Abstracts/Posters

Burden and etiologies of 30-day readmission after bone marrow transplant: Insights from National Readmission Database.
Naveen Premnath, Karan Sud, Sathish Kumar Pondaiah, Arjun Gupta, Journal of Clinical Oncology, 5/20/2019
Analysis of Etiologies At 30 Day Re-Admissions Among Elderly and Young Adults
SK Pondaiah, K Sud, S Zajac, S Shah, LM-Y Chen, N Premnath, R Ernest Jean, American Thoracic Society 2019, 5/1/2019
Impact of Discharge Disposition on 30-day Readmissions Among Patients Admitted with Septic Shock
Karan Sud, Sathish Pondaiah, Naveen Premnath, Christian Olivo-Freites, Raymonde Jean, Critical Care Medicine, 1/1/2019
Septic Shock: Analysis of Etiologies at 30-day Readmissions
Sathish Pondaiah, Karan Sud, Naveen Premnath, Laura Chen, Ermias Jirru, Raymonde Jean, Critical Care Medicine, 1/1/2019
SPEAR: Study of Patients with Para-Pneumonic Pleural Effusion who are Re-Admitted within 30 days
Sathish Pondaiah, Karan Sud, Naveen Premnath, Karishma Bhatia, Adil Shujaat, Chest, 10/1/2018
Dissemination of information on neutropenic diet (ND) by top U.S. cancer centers: In line with evidence?
Dhruvika Mukhija, Naveen Premnath, Arjun Gupta, Anand Venkatraman, Sajan Jiv Singh Nagpal, Journal of Clinical Oncology, 5/20/2018
RETROSPECTIVE REVIEW OF EFFICACY AND DOSE INTENSITY OF SECONDLINE(SL) NAB-PACLITAXEL PLUS GEMCITABINE (NABG) FOR PATIENTS WITHMETASTATIC PANCREATIC ADENOCARCINOMA (MPA...
Shinoj Pattali, Jayakumar Sreenivasan, Naveen Premnath, Shannon Schmidt, Paul S Ritch, James P Thomas, Beth Erickson, Kathleen K Christians, SUsan Tsai, Douglas B Evan..., 50th annual meeting of Pancreas club, https://www.pancreasclub.com/wp-content/uploads/2017/10/PancreasClub_2016finalprogram.pdf, 5/20/2016
Join now to see all

Lectures

Burden and etiologies of 30-day readmission after bone marrow transplant: Insights from National Readmission Database.
2019 ASCO Annual Meeting - 6/1/2019